skip to Main Content
In Record-Setting Veto, Hickenlooper Rejects Bill Adding Autism To Conditions Eligible For Medical Marijuana

Gov. John Hickenlooper on Tuesday set a new benchmark for vetoes in a year as he rejected a measure that would have provided medical marijuana access for people with autism spectrum disorder, saying he could not ignore “overwhelming concerns from the medical community.”

“If we sign that bill we end up, without question, in some way encouraging more young people to look at this as an antidote for their problems,” he told reporters before turning down the legislation, House Bill 1263.

The measure would have added autism spectrum disorder to the list of conditions eligible in Colorado for medical marijuana treatment, a list that includes cancer, glaucoma, HIV or AIDS, post-traumatic stress or certain chronic or debilitating diseases or medical conditions with certain symptoms.

State lawmakers cannot override Hickenlooper’s veto because they are no longer in session.

According to legislative fiscal analysts, 93,314 people were authorized to use medical marijuana in Colorado as of the end of February, 314 of whom were under age 18.

The governor’s office says Hickenlooper on Tuesday met with families of children with autism as he weighed whether to sign House Bill 1263. [Read more at The Denver Post]

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

How Private Equity Trumped Social Equity in State Cannabis Deal

Confidential documents obtained by THE CITY reveal how Chicago Atlantic Group became one of the biggest beneficiaries of the state’s legalization program. Last June, Gov. Kathy Hochul announced that a…

Tech glitch on 4/20 caused Missouri cannabis businesses to lose sales

April 20 is a day recognized globally for celebrating cannabis culture, but it’s also like the cannabis industry’s Black Friday. Dispensaries offer deals designed to inspire people to flood their stores…

Japan’s cannabis market growing rapidly amid regulatory shift

Japan’s cannabis market expanded sixfold over four years to ¥24 billion ($154 million) in 2023, a trend that is expected to accelerate with the amendment in December of cannabis laws,…

Ispire Leads with a Focus on Safety and Innovation

Los Angeles-based Ispire Technologies (NASDAQ: ISPR) is a three-year-old company built on the foundation (and reputation) of a global enterprise with many years of experience as an ODM (original design…

More Categories

Back To Top
×Close search
Search